Journal Report

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Download PDF
Journal Information
Journal Title
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Publisher
AMER SOC MICROBIOLOGY
ISSN
0066-4804
E-ISSN
1098-6596
Database
Clarivate
Domain
Health Sciences, Life Sciences, Physical Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Dual-effective kinase inhibitors as potential treatment of giardiasis and cryptosporidiosis
Matthew A. Hulverson, Samantha A. Michaels, Linh T. Tran et al.
2026-11-10
DOI: 10.1128/aac.00579-26
Population pharmacokinetic analysis of lamivudine (3TC) in HIV-exposed neonates and pediatric participants living with HIV-1 from the IMPAACT 2019 and PETITE studies
Ana Carolina Conchon Costa, Yu-Wei Lin, Hardik Chandasana et al.
2026-11-10
DOI: 10.1128/aac.00701-26
Reply to Jiang et al., “Validating meropenem forecasts for the next dose during CRRT”
Adrian Valadez, Marc H. Scheetz, Michael N. Neely et al.
2026-11-10
DOI: 10.1128/aac.01289-26
<i>In vitro</i> activity of manogepix against <i>Candida</i> spp. displaying elevated echinocandin MIC results
Marisa L. Winkler, John H. Kimbrough, Samuel Edeker et al.
2026-11-10
DOI: 10.1128/aac.00859-26
Validating meropenem forecasts for the next dose during CRRT
Yu Jiang, Ruisi Chen, Peng Li
2026-11-10
DOI: 10.1128/aac.01271-26
Reducing bacterial resistance evolution through antimicrobial peptide modifications
Hadar Cohen Tzemach, Bar Maron, Einav Malach et al.
2026-11-9
DOI: 10.1128/aac.00734-26
SCY-247, a second-generation triterpenoid antifungal, shows low risk for clinically meaningful interactions with CYP3A4 substrates: results from a phase 1 midazolam drug-drug interaction study
Stephen Wring, Christopher Argent, Gail Murphy et al.
2026-11-9
DOI: 10.1128/aac.00961-26
Mining and engineering novel staphylococcal lysostaphins as species-specific antibacterial agents
Michał Bukowski, Aliaksandr Zhydzetski, Alicja Jankowska et al.
2026-11-9
DOI: 10.1128/aac.00845-26
Population pharmacokinetics modeling of albendazole and its active metabolite, albendazole sulfoxide in mass drug administration against lymphatic filariasis
Abdullah Alshehri, Christopher L. King, Daryl J. Murry
2026-11-4 Vol. 70 Issue 11
DOI: 10.1128/aac.00562-26
Development and validation of a cefepime population pharmacokinetic model to guide treatment for patients with hospital-acquired pneumonia requiring renal replacement
Adrian Valadez, Emma Harlan, Marc H. Scheetz et al.
2026-11-4 Vol. 70 Issue 11
DOI: 10.1128/aac.00900-26
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 11, 2026 04:26